Background
==========

In patients with COPD, the process of weaning from mechanical ventilation is frequently complicated and prolonged by physiological and psychological circumstances. The reported rate of weaning failure in COPD is very high, approximately 61%, and as a result, in observed cases, there is 46%--59% prolonged invasive mechanical ventilation.[@b1-copd-11-945],[@b2-copd-11-945] Asynchrony is a particular problem in patients with mechanical ventilation and noninvasive mechanical ventilation,[@b3-copd-11-945],[@b4-copd-11-945] with a reported incidence between 10% and 88% during assisted mechanical ventilation.[@b3-copd-11-945] Patients with COPD commonly experience asynchrony, primarily due to intrinsic positive end-expiratory pressure (PEEP), air trapping, expiratory flow limitation, excessive sedation, and suboptimal ventilator settings during assisted mechanical ventilation. Asynchrony is also associated with prolonged mechanical ventilation, longer intensive care unit stay, mortality, and respiratory muscle dysfunction; and air leaks are also a major cause of asynchrony during noninvasive ventilation.[@b5-copd-11-945]--[@b9-copd-11-945]

Two recent studies found an incidence of asynchrony in 25%--40% of patients on ventilatory assistance. They also found that an asynchrony index \>10% is associated with a significantly prolonged time on ventilatory assistance.[@b10-copd-11-945],[@b11-copd-11-945] In contrast to the findings of Thille and Brochard, De Wit et al, and Chao et al, in the patient group with asynchrony, only 16% were successfully weaned, while 57% in the group without asynchrony were successfully weaned.[@b11-copd-11-945]--[@b13-copd-11-945] In addition, another study by Doorduin et al also demonstrated that poor synchrony (timing errors above 20% between neural drive and pneumatic timing; NeuroSync index) is associated with the number of wasted efforts, which increases the work of breathing and causes NIV failure; worst case scenario will mean intubation in patients with COPD.[@b5-copd-11-945]

Traditional pneumatic modes used for mechanical ventilation are fixed on the basis of pressure and flow within the airways. Unlike the traditional pneumatic modes, neutrally adjusted ventilatory assist (NAVA) is a spontaneous mode, which triggers, cycles, and regulates gas delivery based on the diaphragmatic electromyography signal via a specially designed nasogastric tube (diaphragm electrical activity \[Edi\]).[@b14-copd-11-945]--[@b16-copd-11-945] The level of ventilatory assistance is proportional to the patient's breathing effort, there is no influence of auto-PEEP during the ventilator cycle, since the assistance starts with the patient's breathing effort, and there should not be any influence from leaks during NIV due to better patient-ventilator interaction.[@b14-copd-11-945],[@b17-copd-11-945]

Several studies have compared pneumatic modes (pressure support) to NAVA, with the majority of studies showing that NAVA improves patient-ventilator interaction, diaphragm efficiency, patient comfort (through synchrony), and sleep quality by increasing the slow-wave sleep. Moreover, NAVA can avoid the risk of excessive assistance and reduced ventilatory drive, and improve physiological parameters, with the delivery of lung protective tidal volumes while allowing patients to breathe spontaneously.[@b16-copd-11-945],[@b18-copd-11-945]--[@b23-copd-11-945]

This study hypothesizes that in patients with severe COPD who underwent prolonged mechanical ventilation, NAVA will improve weaning outcome compared to conventional weaning methods by improving patient-ventilator interaction. To date, no clinical studies have been published about the effectiveness of NAVA in COPD patients with prolonged mechanical ventilation. The goal of this study is to compare the effect of NAVA to conventional mode in a randomized controlled trial in patients with severe COPD.

Patients and methods
====================

This study was designed as a prospective, randomized, controlled clinical study to determine the weaning efficacy of NAVA vs conventional modes in patients with COPD who endured weaning failure for more than 21 days. The clinical trial registration number is CMRPGB0382. The study enrolled a total of 37 COPD patients with prolonged mechanical ventilation in the respiratory care center (RCC) of Chang Gung Memorial Hospital between June 2012 and October 2014. This work was performed at Kaohsiung Chang Gung Memorial Hospital, Taiwan. The study was approved by the institutional review board of Chang Gung Memorial Hospital (IRB: 104-09970) and informed consent was obtained from the next of kin prior to start of the study. Inclusion criteria were: 1) older than or equal to 45 years with an established diagnosis of COPD, and 2) mechanical ventilation via intubation or tracheotomy, \>21 days. Exclusion criteria were: 1) consent refused, 2) hemodynamic instability, 3) unable to breathe spontaneously, 4) poor short-term prognosis (defined as a high risk of death within 3 months), and 5) contraindications to the insertion of a nasogastric tube (such as face and nose fracture, recent nose surgery, esophageal obstruction).

After admission to the RCC, all patients were ventilated with a SERVO-i (Maquet, Solna, Sweden), with a clinician-set pressure support level or assist-control. An Edi catheter was inserted within 24 hours if the patient met the inclusion criteria and did not meet any of the exclusion criteria. The breathing capability of the patient was then tested by confirming a stable Edi signal \>2 µV. If the Edi signal remained below this level, the ventilatory assistance has to decrease 30% and observe for 10 minutes. After decreasing the ventilatory 30% for 10 minutes and the Edi signal was still below 2 µV, or end-tidal CO~2~ reached 60 mmHg, the patient was excluded from the study and previous settings were restored. If the Edi signal was still below 2 µV, the patient was excluded from the study and previous settings were restored. Patients able to trigger the ventilator were then randomized to two groups: NAVA and conventional mode. A spontaneous breathing trial (SBT) was performed every 24 hours if the patient met the following criteria: 1) no fever or infection, 2) hemodynamic stability, 3) fraction of inspired oxygen (FiO~2~) \<50%, and 4) PEEP \<8 cmH~2~O. The SBT was performed with a PEEP of 5 cmH~2~O and pressure-support ventilation (PSV) level of 8 cmH~2~O. If the SBT was successful, the patient was evaluated for extubation and noninvasive ventilation. If the patient failed the SBT, he was returned to assisted ventilation with a NAVA setting corresponding to 50% of the peak Edi level during the SBT. The PSV group was returned to a PSV level mandated by the conventional weaning protocol.

Asynchrony events were obtained from the Edi signal and ventilator graphic waveform. The asynchrony index was calculated by comparing the Edi to the flow waveform during 1 minute. The primary outcomes of the study were to establish the detection rate of asynchrony events using waveform analysis or Edi, respectively, and to evaluate the weaning outcome in COPD patients with prolonged mechanical ventilation using NAVA or conventional weaning mode. The secondary outcomes included total length of mechanical ventilation, the length of RCC stay, hospital stay, and mortality rate after 90 days.

Data analysis
=============

Data collection was performed before Edi catheter insertion, post-Edi catheter insertion, after randomization and implementation of the SBT every 24 hours. Data collection included demographic data, prognostic scores, and ventilator and hemodynamic values. Descriptive statistics were expressed as mean ± standard deviation or median and interquartile range depending on the nature and distribution of the variables. Variables normally distributed were compared by the Student's *t*-test. For variables without a normal distribution, the Mann--Whitney *U* rank test was used for comparison. Categorical variables were compared using Fisher's exact test. For all comparisons, a difference of *P*\<0.05 was considered statistically significant. All analyses were performed using SPSS 17.0 software.

Results
=======

We included 37 COPD patients with ventilator dependency for more than 21 days, from June 2012 to October 2014. Four patients were excluded from the analysis due to hemodynamic instability. Flowchart of registered patients was presented in [Figure 1](#f1-copd-11-945){ref-type="fig"}. The demographic and patient characteristics were presented in [Table 1](#t1-copd-11-945){ref-type="table"}. Clinical data were collected during three different periods: T0: immediately after Edi catheter insertion, T1: after intervention, and T2: at the end of the SBT trial ([Table 2](#t2-copd-11-945){ref-type="table"}).

After admission to the RCC, an Edi catheter was inserted in all study subjects within 24 hours. Asynchrony recognition rates before and after Edi catheter insertion were described in [Figure 2](#f2-copd-11-945){ref-type="fig"}. Asynchrony incidence diagnosed without Edi catheter was 60.6% and after Edi catheter insertion was 87.9% (*P*\<0.001). Asynchrony index without Edi catheter was 7.4% and after Edi catheter insertion was 13.2% (*P*\<0.01). The asynchrony events calculated from the flow waveforms and Edi signals, respectively, were: ineffective trigger 30.3% vs 54.5% (*P*\<0.005); delayed trigger 6.1% vs 27.2% (*P*\<0.008); flow asynchrony 6.1% vs 18.1% (*P*\<0.04); double triggering 9.1% vs 18.1% (*P*\<0.08); auto triggering 9.1% vs 15.1% (*P*\<0.15), and delayed cycling 0% vs 3.0% (*P*\<0.15).

Asynchrony classification and incidence for NAVA and conventional group were shown in [Table 3](#t3-copd-11-945){ref-type="table"}. Asynchrony index in NAVA vs conventional mode was 0% vs 11.9% (*P*\<0.001); ineffective trigger 0% vs 52.6% (*P*\<0.001); delayed trigger 0% vs 36.8% (*P*\<0.001); flow asynchrony 0% vs 26.3% (*P*\<0.001); and double triggering 0% vs 21.1% (*P*\<0.001). The main asynchrony events in this study were ineffective triggering (42.1%), delayed trigger (31.6%), flow asynchrony (26.3%), and double triggering (21.1%) in the conventional group. The asynchrony index was displayed in [Figure 3](#f3-copd-11-945){ref-type="fig"} and the accumulated asynchrony numbers were displayed in [Figure 4](#f4-copd-11-945){ref-type="fig"}. Outcomes in the NAVA and control group were described in [Table 4](#t4-copd-11-945){ref-type="table"}. Mortality rate in NAVA vs the control group in the RCC was 7.1% vs 31.6% (*P*=0.09); 90-day mortality was 28.6% vs 31.6% (*P*=0.85); total RCC stay days were 20.3 d ±12.2 d vs 22.1 d ±21.1 d (*P*=0.78); and total ventilator days were 47.3 d ±28.8 d vs 49.2 d ±36.0 d (*P*=0.94).

Discussion
==========

The main finding of this study demonstrates that NAVA improves patient-ventilator interaction compared to conventional mode in COPD patients with prolonged mechanical ventilation. COPD patients with acute respiratory failure requiring mechanical ventilation have frequent episodes of patient-ventilator asynchrony.[@b3-copd-11-945],[@b7-copd-11-945],[@b24-copd-11-945] According to Thille et al and Thille and Brochard, one quarter of all patients had a high rate of asynchrony during assisted ventilation; interestingly, the incidence of asynchrony was nearly 82% in patients who received PSV and 18% during assist-control ventilation.[@b10-copd-11-945],[@b11-copd-11-945] In our study, 80% (N=23) of the patients who were transferred to our RCC, had a high level of pressure support (PSV level \>15 cmH~2~O) or assist-control ventilation, and incidence of asynchrony was nearly 84% in the control group (N=16). This demonstrates that poor patient-ventilator interaction is a common problem in patients with COPD during invasive mechanical ventilation.

On the other hand, in our study, the Edi catheter could effectively provide a real-time demonstration of the degree of synchrony/asynchrony between the patient's diaphragmatic activity and the conventionally triggered assisted breath.[@b25-copd-11-945] Our asynchrony recognition rate after insertion of the Edi catheter was significantly different (*P*\<0.05), indicating that monitoring based on the Edi signal could increase the ability to recognize the rate and the type of asynchrony in difficult to wean patients. The benefit of the Edi signal is enhanced respiratory monitoring. Respiratory monitoring using the Edi signal not only increases the ability to recognize the rate and the type of asynchrony, but may also aid clinical staff in resolving problems earlier.[@b26-copd-11-945] Moreover, NAVA will improve patient-ventilator interaction owing to the fact that the pressure applied by the ventilator to the airway opening is proportional to the Edi signal. Sixty-nine percent (N=9) of patients in the NAVA group had better triggering after the change from conventional mode to NAVA mode.

Patients with COPD are regarded as particularly difficult to wean after prolonged mechanical ventilation, in our experience more than 21 days.[@b27-copd-11-945] Our patients were characterized by old age (\>75 years), high Acute Physiology and Chronic Health Enquiry (APACHE) II score (18.2±4.6), moderate obstructive pulmonary disease with multiple organ failure (Sequential Organ Failure Assessment \[SOFA\] Scale 4.1±2.5), and hypo-albuminuria (albumin \[ALB\] \<3 g/dL). In patients with COPD, the process of weaning from mechanical ventilation is frequently complicated and prolonged by physiological and psychological circumstances such as old age, poor lung function, expiratory flow limitation, air trapping, increased intrinsic PEEP, patient discomfort, dyspnea, and sleep fragmentation, leading to a prolonged weaning process.[@b21-copd-11-945],[@b28-copd-11-945],[@b29-copd-11-945]

The weaning outcome and mortality in the NAVA group was better than the conventional group, although the weaning outcome was not significantly different, and some significant physiological results were also found in this study. Hence, further research should focus on enrolling a larger number of patients and recording some index of comfort in order to demonstrate better comfort than pneumatic modes and shorter weaning time in patients with COPD after prolonged mechanical ventilation.

Limitations
===========

There is one major limitation in this study. Our study population was small and it was a single-center trial, hence, the result in weaning outcome is not statistically significant in this study. Although a better drive in NAVA mode, it could be improved if we measure index of comfort in this study.

Conclusion
==========

Compared to conventional monitoring, Edi signal can significantly enhance respiratory monitoring, increasing the ability to recognize the rate and type of asynchrony. Compared to conventional pneumatic trigger, NAVA Edi trigger significantly improved patient-ventilator asynchrony, reduced work of breathing, and enhanced patient comfort by better synchrony in our COPD patients with prolonged mechanical ventilation. The NAVA mode also shows a trend in outcome benefit in the field of RCC mortality.
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![Flowchart of registered patients.\
**Abbreviations:** NAVA, neurally adjusted ventilatory assist; PSV, pressure-support ventilation; Edi, diaphragm electrical activity; PEEP, positive end-expiratory pressure.](copd-11-945Fig1){#f1-copd-11-945}

![Asynchrony recognition rate before and after Edi catheter insertion.\
**Notes:** Frequencies and Pearson's chi-squared test. ^\*^*P*\<0.05; ^\*\*^*P*\<0.01; ^\*\*\*^*P*\<0.001.\
**Abbreviation:** Edi, diaphragm electrical activity.](copd-11-945Fig2){#f2-copd-11-945}

![Asynchrony index of the all patients.\
**Notes:** Filled circles indicate individual asynchrony index of each patient. Fourteen patients had AI \>10% in the control group, but no patients had AI in NAVA mode.\
**Abbreviations:** NAVA, neurally adjusted ventilatory assist; AI, asynchrony index.](copd-11-945Fig3){#f3-copd-11-945}

![Accumulated asynchrony numbers of the NAVA and control group.\
**Abbreviation:** NAVA, neurally adjusted ventilatory assist.](copd-11-945Fig4){#f4-copd-11-945}

###### 

Patient characteristics

  Variables                     NAVA (n=14)   Conventional (n=19)   *P*-value
  ----------------------------- ------------- --------------------- -----------
  Sex n(%)                                                          
   Male                         11 (78.6%)    13 (68.4%)            0.51
   Female                       3 (21.4%)     6 (31.6%)             
  Age, years                    79.3±6.2      76.9±9.3              0.62
  IBW (Kg)                      53.6±11.2     55.7±1.7              0.82
  Total ICU, days               19.4±11.8     22.3±19.4             0.08
  Ventilator days before        26.9±10.7     27.1±13.0             0.41
  PFT (before admission)                                            
   FEV~1~/Pred (%)              59.0±15.5     53.5±16.5             0.51
   FEV~1~/FVC (%)               64.8±18.8     71.9±17.7             0.12
  SOFA score                    3.7±2.8       4.3±2.5               0.32
  APACHE II                                                         
   Mean                         17.4±4.1      18.7±5.0              0.42
   ≥15                          10 (71.4%)    15 (78.9%)            0.59
  Acute lung injury                                                 
   Sepsis                       0 (0%)        15.3%                 0.38
   Bacterial pneumonia          6 (42.9%)     6 (31.6%)             0.50
  ICU ventilator data                                               
   TV (mL)                      415.9±128.7   511.0±79.9            0.02
   TV of IBW (mL/kg)            6.8±1.9       9.4±1.4               0.01
   RR, breath/min               23.3±5.5      19.7±6.4              0.05
   MV (L)                       9.0±2.7       9.3±2.3               0.89
   RSBI                         64.1±28.9     80.9±38.0             0.42
  Respiratory muscle strength                                       
   MIP (cmH~2~O)                22.9±9.3      26.4±9.0              0.35
   MEP (cmH~2~O)                25.5±14.3     26.9±18               0.73
  Nutrition                                                         
   ALB (3.5--5 g/dL)            2.6±9.3       2.7±9.3               0.68

**Notes:** Pearson chi-square test was used for sex, Student's *t*-test was used for age, body weight, total ICU days, ventilator days before included, and nonparametric method for APACHE II and nutrition. Data is presented as either n(%) or mean ± SD.

**Abbreviations:** IBW, ideal body weight; PFT, pulmonary function test; TV, tidal volume; RR, respiratory rate; MV, minute volume; RSBI, rapid shallow breathing index; MIP, maximum inspiratory pressure; MEP, maximum expiratory pressure; NAVA, neutrally adjusted ventilatory assist; ICU, intensive care unit; FEV~1~/pred, predicted forced expiratory volume in 1 second; FEV~1~/FVC, forced expiratory volume in 1 second/forced vital capacity; APACHE II, Acute Physiology and Chronic Health Enquiry II; ALB, albumin; SOFA, Sequential Organ Failure Assessment.

###### 

Clinical data collection by T0, T1, T2[a](#tfn3-copd-11-945){ref-type="table-fn"}

  Variables                                          NAVA (n=14)   Conventional (n=19)   *P*-value            
  -------------------------------------------------- ------------- --------------------- ----------- -------- ------
  T0: data immediately post-Edi catheter insertion                                                            
   TV (mL)                                           424.9         ±102.4                448.9       ±100.6   0.71
   TV of IBW (mL/kg)                                 7.1           ±1.9                  8.3         ±1.9     0.09
   RR, breath/min                                    22.3          ±5.2                  22.8        ±7.3     0.21
   MV (L)                                            9.7           ±2.1                  9.4         ±2.1     0.78
   TV/Edi (NVE)                                      71.9          ±41.9                 92.9        ±66.9    0.48
   RSBI                                              64.1          ±28.9                 80.9        ±38.0    0.42
   MIP (cmH~2~O)                                     20.0          ±1.0                  20.5        ±9.3     0.71
   MEP (cmH~2~O)                                     14.0          ±0.1                  21.5        ±10.6    0.46
   P0.1, cmH~2~O                                     1.1           ±1.0                  1.0         ±1.1     0.81
   PEEPi, cmH~2~O                                    2.3           ±3.4                  3.9         ±3.7     0.27
   ALB (3.5--5 g/dL)                                 1.7           ±1.5                  2.4         ±0.5     0.23
  T1: data after intervention                                                                                 
  Ventilator data                                                                                             
   TV (mL)                                           435.7         ±109.3                463.3       ±104.3   0.42
   TV of IBW (mL/kg)                                 7.2           ±1.8                  8.5         ±1.8     0.05
   RR, breath/min                                    26.0          ±6.7                  23.2        ±8.7     0.23
   MV (L)                                            10.5          ±2.0                  10.2        ±3.2     0.68
   TV/Edi (NVE)                                      74.7          ±54.9                 89.5        ±70.1    0.71
   RSBI                                              91.6          ±57.9                 127.1       ±141.3   0.55
   MIP (cmH~2~O)                                     25.4          ±12.6                 26.0        ±14      0.96
   MEP (cmH~2~O)                                     32.0          ±20.2                 26.1        ±24      0.21
   P0.1, cmH~2~O                                     1.2           ±1.7                  1.1         ±0.9     0.84
   PEEPi, cmH~2~O                                    2.4           ±4.9                  2.7         ±3.6     0.77
   ALB (3.5--5 g/dL)                                 1.7           ±1.5                  2.4         ±0.5     0.51
  T2: data at the end of SBT trial                                                                            
   TV (mL)                                           373.8         ±80.9                 391.6       ±87.7    0.67
   TV of IBW (mL/kg)                                 6.1           ±1.1                  7.2         ±1.6     0.05
   RR, breath/min                                    24.7          ±4.7                  25.7        ±8.7     0.87
   MV (L)                                            8.9           ±2.1                  9.4         ±2.3     0.51
   TV/Edi (NVE)                                      54.0          ±52.5                 54.4        ±49.9    0.86
   RSBI                                              104.6         ±54.2                 129.6       ±120.7   0.87
   MIP (cmH~2~O)                                     30.9          ±12.6                 26.7        ±11.1    0.42
   MEP (cmH~2~O)                                     31.6          ±17.8                 25.9        ±23.2    0.16
   ALB (3.5--5 g/dL)                                 2.5           ±0.7                  3.0         ±0.1     0.31

**Notes:**

Nonparametric method. Data presented as mean ± standard deviation.

**Abbreviations:** IBW, ideal body weight; NAVA, neutrally adjusted ventilatory assist; TV, tidal volume; RR, respiratory rate; MV, minute volume; RSBI, rapid shallow breathing index; MIP, maximum inspiratory pressure; MEP, maximum expiratory pressure; Edi, diaphragm electrical activity; NVE, tidal volume/neuro-ventilatory efficiency; PEEPi, intrinsic positive end-expiratory pressure; SBT, spontaneous breathing trial; ALB, albumin; p0.1, negative airway pressure generated during the first 100 msec of an occluded inspiration.

###### 

Asynchrony index between NAVA and control group (n=33)

  Variables n(%)         NAVA (n=14)   Conventional (n=19)   *P*-value
  ---------------------- ------------- --------------------- -----------
  Asynchrony index       0             16(84.2)              \<0.001
  Asynchrony incidence   0             16(84.2)              \<0.001
  Ineffective trigger    0             10(52.6)              \<0.001
  Delayed trigger        0             7(36.8)               \<0.001
  Flow asynchrony        0             5(26.3)               \<0.001
  Double triggering      0             4(21.1)               \<0.001
  Auto triggering        0             0/0                   --
  Premature cycling      0             0/0                   --
  Delayed cycling        0             0/0                   --

**Abbreviation:** NAVA, neurally adjusted ventilatory assist.

###### 

Weaning outcome after NAVA and conventional mode

  Variables, total (n=33)           NAVA (n =14)   Conventional (n=19)   *P*-value            
  --------------------------------- -------------- --------------------- ----------- -------- ------
  RCC mortality (%)                 1              (7.1)                 6           (31.6)   0.09
  90 days mortality (%)             4              (28.6)                6           (31.6)   0.94
  Total RCC days                    20.3           ±12.2                 22.1        ±21.1    0.78
  Ventilator-free days in 1 month   11.6           ±9.0                  12.2        ±9.4     0.84
  Total ventilator days             47.3           ±28.8                 49.2        ±36.0    0.85
  Total hospital days               77.0           ±40.0                 71.7        ±39.1    0.92

**Notes:** Data were presented as either n (%) or mean ± SD.

**Abbreviations:** NAVA, neurally adjusted ventilatory assist; RCC, respiratory care center.
